Key Takeaways CAH will report Q3 fiscal 2026 earnings on April 30; estimates call for $62.4B sales and $2.81 EPS. CAH's specialty business is poised to exceed $50B in fiscal 2026, led by oncology and biopharma services. Existing holders may stay put, while new investors may wait for results and updated commentary.Cardinal Health (CAH) is set to report third-quarter fiscal 2026 earnings on April 30. The Zacks Consensus Estimate for sales and earnings is pegged at $62.4 billion and $2.81 per share, respective ...